These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6381597)

  • 1. Roles of V antigen in promoting virulence and immunity in yersiniae.
    Une T; Brubaker RR
    J Immunol; 1984 Oct; 133(4):2226-30. PubMed ID: 6381597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of V antigen in promoting virulence in Yersiniae.
    Une T; Nakajima R; Brubaker RR
    Contrib Microbiol Immunol; 1987; 9():179-85. PubMed ID: 3665496
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity.
    Schmidt A; Schaffelhofer S; Müller K; Röllinghoff M; Beuscher HU
    Microb Pathog; 1999 Apr; 26(4):221-33. PubMed ID: 10089162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
    Vogel U; Autenrieth IB; Berner R; Heesemann J
    Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens.
    Simonet M; Berche P; Mazigh D; Veron M
    J Med Microbiol; 1985 Oct; 20(2):225-31. PubMed ID: 3900406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen.
    Roggenkamp A; Geiger AM; Leitritz L; Kessler A; Heesemann J
    Infect Immun; 1997 Feb; 65(2):446-51. PubMed ID: 9009295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae.
    Une T; Brubaker RR
    Infect Immun; 1984 Mar; 43(3):895-900. PubMed ID: 6365786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide.
    Motin VL; Nakajima R; Smirnov GB; Brubaker RR
    Infect Immun; 1994 Oct; 62(10):4192-201. PubMed ID: 7927675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological response of sheep to plasmid-encoded proteins of Yersinia species following natural infection with Y. enterocolitica and Y. pseudotuberculosis.
    Robins-Browne RM; Bordun AM; Slee KJ
    J Med Microbiol; 1993 Oct; 39(4):268-72. PubMed ID: 8411087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to plasmid- and chromosome-encoded Yersinia antigens.
    Mazza G; Karu AE; Kingsbury DT
    Infect Immun; 1985 Jun; 48(3):676-85. PubMed ID: 3997240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype 08 by macrophages.
    Roggenkamp A; Leitritz L; Sing A; Kempf VA; Baus K; Heesemann J
    Med Microbiol Immunol; 1999 Dec; 188(3):151-9. PubMed ID: 10776846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vwa+ phenotype of Yersinia enterocolitica.
    Perry RD; Brubaker RR
    Infect Immun; 1983 Apr; 40(1):166-71. PubMed ID: 6832830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the virulence gene products of Yersinia enterocolitica in the immune response of infected mice.
    Takeuchi O; Suzuki T; Kawamura I; Kobayashi N; Takizawa-Hashimoto A; Mitsuyama M
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):321-9. PubMed ID: 16019194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The V antigen of yersiniae: an overview.
    Brubaker RR
    Contrib Microbiol Immunol; 1991; 12():127-33. PubMed ID: 1935079
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral infection by Y. enterocolitica 0:8. Studies of immunization in a murine model].
    Frades MC; Díaz R
    Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):608-12. PubMed ID: 1822150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens].
    Rastawicki W
    Med Dosw Mikrobiol; 2008; 60(1):27-37. PubMed ID: 18634341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the low-calcium response in Yersinia pestis via plasmid-plasmid interaction.
    Sample AK; Fowler JM; Brubaker RR
    Microb Pathog; 1987 Jun; 2(6):443-53. PubMed ID: 3507558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.
    Nakajima R; Brubaker RR
    Infect Immun; 1993 Jan; 61(1):23-31. PubMed ID: 8418045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serodiagnosis of human infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
    Chart H; Cheasty T
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):391-7. PubMed ID: 16872375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.